The Care Notebook

When thymalfasin comes up

Budget notes

Get a written total, not a headline.

The mix-up

Myth: There is a standard approved US price for this treatment.

The answer

As of September 28, 2026, the FDA has approved no US product with this peptide. The FDA is the US medicine regulator.

Why a dollar figure is missing

Without an approved US product, there is no official US list price from a manufacturer or the government.

A clinic or pharmacy quote for this peptide is not the price of an FDA-approved US medicine.

Ask what product the quote describes and how it would be supplied. Settle that question alongside the cost question.

FDA record on the absence of an approved product

Ask for the whole proposed bill

  • What is the visit fee?
  • Are tests billed separately?
  • Is medicine included, and is delivery separate?
  • Is there a recurring fee or a minimum commitment?
  • What would follow-up cost?
  • How do cancellation and refunds work?

Ask the insurance plan separately

Give your plan the exact proposed product and service names. Ask about the visit and any tests as separate items.

Ask what the plan would pay, how much would fall to you, and whether care needs the plan's permission in advance. Request the answer in writing.

A quote and an insurance answer belong beside each other in your notes before you agree to pay.

Choose a different note